FdaApplication
ANDA 211521
Identifiers
- fda_app_no: ANDA211521
Properties
| Property | Value |
|---|---|
| applicant_name | TARO PHARMACEUTICAL INDUSTRIES LTD |
| application_type | ANDA |
| approval_date | 2019-12-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZITHROMYCIN | AZITHROMYCIN | EQ 200MG BASE/5ML | FOR SUSPENSION;ORAL |
1 product